Skip to content
Home
Company
Leadership
Scientific Advisors
Board
ESG
Science
Targeting the DDR
DcoDeR platform
Pipeline
Our Pipeline
ATR Inhibitor ART0380
Pol Theta Inhibitor Program
Drug Discovery Platform
Investors & Partners
Our Investors
Our Partners
Merck KGaA
Novartis
Careers & Culture
Our Opportunities
Our Testimonials
Our Benefits
Core Values
News & Events
Press release
Media coverage
Conferences
Contact Us
Scientific advisors
Dr Simon J. Boulton, FMedSci FRS
15 March 2022
Professor Chris Lord
28 November 2019
Professor Geoff Higgins
27 November 2019
Dr Stephen V. Frye
27 November 2019
© Artios Pharma 2024 | Website by
Granite 5
Follow on twitter
Follow on LinkedIn
Terms & conditions
|
Privacy policy
|
Site map
We use cookies to collect data, please see our
privacy policy
.